Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Fleischer

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|July 16, 2015
Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypesBalázs Győrffy, Giulia Bottai, Thomas Fleischer, et al.
Clinical Epigenetics|July 21, 2025
DNA methylation in normal-appearing tissue associated with prostate cancer recurrence and metastasisChristine Aaserød Pedersen, Thomas Fleischer, Maximilian Wess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
DNA methylation status of key cell-cycle regulators such as CDKNA2/p16 and CCNA1 correlates with treatment response to doxorubicin and 5-fluorouracil in locally advanced breast tumorsJovana Klajic, Florence Busato, Hege Edvardsen, et al.
Clinical Epigenetics|July 28, 2015
DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancerKevin C Johnson, Devin C Koestler, Thomas Fleischer, et al.
Molecular Systems Biology|March 22, 2021
Multi-modal meta-analysis of cancer cell line omics profiles identifies ECHDC1 as a novel breast tumor suppressorAlok Jaiswal, Prson Gautam, Elina A Pietilä, et al.
Molecular Oncology|April 27, 2024
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancerThomas Fleischer, Mads Haugland Haugen, Jørgen Ankill, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgeryÅslaug Helland, Hege Marian Skaug, Lilach Kleinberg, et al.
Cancers|September 28, 2023
MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer PatientsTorgeir Mo, Siri Helene Bertelsen Brandal, Oliver Marcel Geier, et al.
BMC Cancer|October 8, 2013
Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumorsJovana Klajic, Thomas Fleischer, Emelyne Dejeux, et al.
Genes|February 25, 2023
<i>ABCB1</i> Amplicon Contains Cyclic AMP Response Element-Driven <i>TRIP6</i> Gene in Taxane-Resistant MCF-7 Breast Cancer SublinesPetr Daniel, Kamila Balušíková, Radka Václavíková, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|July 16, 2015
Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypesBalázs Győrffy, Giulia Bottai, Thomas Fleischer, et al.
Clinical Epigenetics|July 21, 2025
DNA methylation in normal-appearing tissue associated with prostate cancer recurrence and metastasisChristine Aaserød Pedersen, Thomas Fleischer, Maximilian Wess, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
DNA methylation status of key cell-cycle regulators such as CDKNA2/p16 and CCNA1 correlates with treatment response to doxorubicin and 5-fluorouracil in locally advanced breast tumorsJovana Klajic, Florence Busato, Hege Edvardsen, et al.
Clinical Epigenetics|July 28, 2015
DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancerKevin C Johnson, Devin C Koestler, Thomas Fleischer, et al.
Molecular Systems Biology|March 22, 2021
Multi-modal meta-analysis of cancer cell line omics profiles identifies ECHDC1 as a novel breast tumor suppressorAlok Jaiswal, Prson Gautam, Elina A Pietilä, et al.
Molecular Oncology|April 27, 2024
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancerThomas Fleischer, Mads Haugland Haugen, Jørgen Ankill, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 31, 2011
EGFR gene alterations in a Norwegian cohort of lung cancer patients selected for surgeryÅslaug Helland, Hege Marian Skaug, Lilach Kleinberg, et al.
Cancers|September 28, 2023
MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer PatientsTorgeir Mo, Siri Helene Bertelsen Brandal, Oliver Marcel Geier, et al.
BMC Cancer|October 8, 2013
Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumorsJovana Klajic, Thomas Fleischer, Emelyne Dejeux, et al.
Genes|February 25, 2023
<i>ABCB1</i> Amplicon Contains Cyclic AMP Response Element-Driven <i>TRIP6</i> Gene in Taxane-Resistant MCF-7 Breast Cancer SublinesPetr Daniel, Kamila Balušíková, Radka Václavíková, et al.
Pageof 5